CORYOL 6,25MG Tableta Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

coryol 6,25mg tableta

krka, d.d., novo mesto, novo mesto array - 9168 karvedilol - tableta - 6,25mg - karvedilol

LODOZ 10MG/6,25MG Potahovaná tableta Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

lodoz 10mg/6,25mg potahovaná tableta

merck spol. s r.o., praha array - 10087 bisoprolol-fumarÁt; 728 hydrochlorothiazid - potahovaná tableta - 10mg/6,25mg - bisoprolol a thiazidy

LODOZ 2,5MG/6,25MG Potahovaná tableta Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

lodoz 2,5mg/6,25mg potahovaná tableta

merck spol. s r.o., praha array - 10087 bisoprolol-fumarÁt; 728 hydrochlorothiazid - potahovaná tableta - 2,5mg/6,25mg - bisoprolol a thiazidy

LODOZ 5MG/6,25MG Potahovaná tableta Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

lodoz 5mg/6,25mg potahovaná tableta

merck spol. s r.o., praha array - 10087 bisoprolol-fumarÁt; 728 hydrochlorothiazid - potahovaná tableta - 5mg/6,25mg - bisoprolol a thiazidy

SOBYCOR COMBI 10MG/10MG Tableta Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

sobycor combi 10mg/10mg tableta

krka, d.d., novo mesto, novo mesto array - 10087 bisoprolol-fumarÁt; 12990 amlodipin-besilÁt - tableta - 10mg/10mg - bisoprolol a amlodipin

SOBYCOR COMBI 10MG/5MG Tableta Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

sobycor combi 10mg/5mg tableta

krka, d.d., novo mesto, novo mesto array - 10087 bisoprolol-fumarÁt; 12990 amlodipin-besilÁt - tableta - 10mg/5mg - bisoprolol a amlodipin

SOBYCOR COMBI 5MG/10MG Tableta Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

sobycor combi 5mg/10mg tableta

krka, d.d., novo mesto, novo mesto array - 10087 bisoprolol-fumarÁt; 12990 amlodipin-besilÁt - tableta - 5mg/10mg - bisoprolol a amlodipin

Hemangiol Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

hemangiol

pierre fabre medicament - propranolol-hydrochloridu - hemangiom - beta blokátory - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.